Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varlitinib + mFOLFOX6 in advanced gastric cancer
NCT03130790Phase 3Completed
- Sponsor
- ASLAN Pharmaceuticals
- Start
- Aug 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of varlitinib in gastric cancer (GC), sponsored by ASLAN Pharmaceuticals. Started Aug 2017; status: completed.
02
Drugs
varlitinib
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT03130790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03130790.